{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:47:03Z","timestamp":1791388023443,"version":"4.3.3"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbrc.2025.152950","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:09:39Z","timestamp":1762618179000},"page":"152950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["mRNA vaccines for porcine reproductive and respiratory syndrome: A new paradigm in swine health"],"prefix":"10.1016","volume":"791","author":[{"given":"Mirwaise","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2328-6682","authenticated-orcid":false,"given":"Osamu","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152950_bib1","first-page":"554","article-title":"Epidemiological review of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Japan: from discovery and spread to economic losses and future prospects","volume":"12","author":"Taira","year":"2025","journal-title":"Vet. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib2","series-title":"Porcine Reproductive and Respiratory Syndrome","author":"Frossard","year":"2024"},{"key":"10.1016\/j.bbrc.2025.152950_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.952383","article-title":"An assessment of enhanced biosecurity interventions and their impact on porcine reproductive and respiratory syndrome virus outbreaks within a managed group of farrow-to-wean farms, 2020\u20132021","volume":"9","author":"Havas","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/ani13050813","article-title":"Research progress on glycoprotein 5 of porcine reproductive and respiratory syndrome virus","volume":"13","author":"Luo","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.bbrc.2025.152950_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00709-24","article-title":"PRRSV-2 variant classification: a dynamic nomenclature for enhanced monitoring and surveillance","volume":"10","author":"VanderWaal","year":"2025","journal-title":"mSphere"},{"key":"10.1016\/j.bbrc.2025.152950_bib6","article-title":"Mechanism, structural and functional insights into nidovirus-induced double-membrane vesicles","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152950_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/v17040506","article-title":"Cinnamaldehyde inhibits the replication of porcine reproductive and respiratory syndrome virus type 2 in vitro","volume":"17","author":"Song","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152950_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/pathogens11020271","article-title":"Methods of inactivation of highly pathogenic viruses for molecular, serology or vaccine development purposes","volume":"11","author":"Elveborg","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.bbrc.2025.152950_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-021-01311-z","article-title":"mRNA vaccine: a potential therapeutic strategy","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2025.152950_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.procbio.2022.12.002","article-title":"Lessons learned from COVID-19 pandemic: Vaccine platform is a key player","volume":"124","author":"Alhashemi","year":"2023","journal-title":"Process Biochem."},{"key":"10.1016\/j.bbrc.2025.152950_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","article-title":"The storage and in-use stability of mRNA vaccines and therapeutics: not a cold case","volume":"112","author":"Oude Blenke","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2024.110252","article-title":"The evolution and diversity of porcine reproductive and respiratory syndrome virus in China","volume":"298","author":"Zhou","year":"2024","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib13","article-title":"Analysis of the genetic evolution and recombination of the PRRSV-2 GP2 protein in China from 1996 to 2023","volume":"13","author":"Liu","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2025.152950_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2025.110534","article-title":"The mRNA vaccine expressing fused structural protein of PRRSV protects piglets against PRRSV challenge","author":"Mou","year":"2025","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259531","article-title":"Porcine reproductive and respiratory syndrome virus 2 (PRRSV-2) genetic diversity and occurrence of wild type and vaccine-like strains in the United States swine industry","volume":"16","author":"Kikuti","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152950_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40813-016-0037-y","article-title":"Vaccination of piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX\u00ae EU provides protection against heterologous field challenge in the face of homologous maternally derived antibodies","volume":"2","author":"Balka","year":"2016","journal-title":"Porcine Health Manag."},{"key":"10.1016\/j.bbrc.2025.152950_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5501\/wjv.v1.i1.23","article-title":"Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects","volume":"1","author":"Charerntantanakul","year":"2012","journal-title":"World J. Virol."},{"key":"10.1016\/j.bbrc.2025.152950_bib18","article-title":"Complete genome sequence of a novel variant porcine reproductive and respiratory syndrome virus (PRRSV) strain: evidence for recombination between vaccine and wild-type PRRSV strains","author":"Wenhui","year":"2012","journal-title":"Am. Soc. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/v15071442","article-title":"Progress in PRRSV infection and adaptive immune response mechanisms","volume":"15","author":"Cai","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152950_bib20","series-title":"Immunology, and Pathogenesis","article-title":"Porcine reproductive and respiratory syndrome virus-animal virology","author":"Guo","year":"2023"},{"key":"10.1016\/j.bbrc.2025.152950_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/vaccines12121387","article-title":"Current status of Porcine reproductive and respiratory syndrome vaccines","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines."},{"key":"10.1016\/j.bbrc.2025.152950_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-45-12","article-title":"Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation","volume":"45","author":"Han","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.bbrc.2025.152950_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vetmic.2018.08.008","article-title":"Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts","volume":"223","author":"Jeong","year":"2018","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vetmic.2017.09.002","article-title":"Phenotypic characterization of a highly pathogenic Italian porcine reproductive and respiratory syndrome virus (PRRSV) type 1 subtype 1 isolate in experimentally infected pigs","volume":"210","author":"Canelli","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib25","series-title":"An Overview of Veterinary Viral Diseases and Vaccine Technologies, Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols","first-page":"1","author":"Brun","year":"2022"},{"key":"10.1016\/j.bbrc.2025.152950_bib26","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2014.04.083","article-title":"Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152950_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13567-022-01082-5","article-title":"A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge","volume":"53","author":"Chen","year":"2022","journal-title":"Vet. Res."},{"key":"10.1016\/j.bbrc.2025.152950_bib28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3389\/fmicb.2017.01635","article-title":"Improved vaccine against PRRSV: current progress and future perspective","volume":"8","author":"Nan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib29","article-title":"Efficacy of the synergy between live-attenuated and inactivated PRRSV vaccines against a NADC30-like strain of porcine reproductive and respiratory syndrome virus in 4-week piglets","volume":"9","author":"Li","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetimm.2011.01.002","article-title":"Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs","volume":"140","author":"Chia","year":"2011","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.bbrc.2025.152950_bib31","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.vaccine.2015.04.102","article-title":"Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: current status and future direction","volume":"33","author":"Renukaradhya","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152950_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.729879","article-title":"A new look at vaccine strategies against PPRV focused on adenoviral candidates","volume":"8","author":"Rojas","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/vim.2019.0092","article-title":"Recombinant porcine interferon alpha enhances immune responses to killed porcine reproductive and respiratory syndrome virus vaccine in pigs","volume":"32","author":"Yu","year":"2019","journal-title":"Viral Immunol."},{"key":"10.1016\/j.bbrc.2025.152950_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/vaccines13030260","article-title":"Porcine reproductive and respiratory syndrome virus: challenges and advances in vaccine development","volume":"13","author":"He","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.bbrc.2025.152950_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virusres.2010.06.017","article-title":"Vectored vaccines to protect against PRRSV","volume":"154","author":"Cruz","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2025.152950_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2025.152950_bib37","article-title":"Development and delivery systems of mRNA vaccines","volume":"9","author":"Liang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152950_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152950_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/v15030668","article-title":"Research advances on the stability of mRNA vaccines","volume":"15","author":"Cheng","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152950_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbrc.2025.152950_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/v14020401","article-title":"mRNA vaccine development for emerging animal and zoonotic diseases","volume":"14","author":"Le","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152950_bib42","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152950_bib43","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/ani10122343","article-title":"Selected biological medicinal products and their veterinary use","volume":"10","author":"Zygmuntowicz","year":"2020","journal-title":"Animals"},{"key":"10.1016\/j.bbrc.2025.152950_bib44","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/pharmaceutics17070803","article-title":"Endo\/Lysosomal-escapable lipid nanoparticle platforms for enhancing mRNA delivery in cancer therapy","volume":"17","author":"Wang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2025.152950_bib45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nano.2015.11.001","article-title":"Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines","volume":"12","author":"D\u00e9moulins","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bbrc.2025.152950_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biomaterials.2017.02.019","article-title":"Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination","volume":"125","author":"Persano","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152950_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/pharmaceutics14010078","article-title":"Cell-penetrating peptides: emerging tools for mRNA delivery","volume":"14","author":"Yokoo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2025.152950_bib48","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2025.152950_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2025.152950_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.167","article-title":"mRNA vaccines in the prevention and treatment of diseases","volume":"3","author":"Gu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.bbrc.2025.152950_bib51","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.3390\/ijms21186582","article-title":"mRNA vaccine era\u2014mechanisms, drug platform and clinical prospection","volume":"21","author":"Xu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib52","article-title":"Development of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) mRNA vaccine against highly pathogenic PRRSV challenge","volume":"44","author":"Khan","year":"2024","journal-title":"Pak. Vet. J."},{"key":"10.1016\/j.bbrc.2025.152950_bib53","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500 from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2025.152950_bib54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152950_bib55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbrc.2025.152950_bib56","doi-asserted-by":"crossref","first-page":"34011","DOI":"10.1021\/acsami.0c05489","article-title":"Development of a microfluidic-based post-treatment process for size-controlled lipid nanoparticles and application to siRNA delivery","volume":"12","author":"Kimura","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbrc.2025.152950_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","article-title":"Tailoring mRNA vaccine to balance innate\/adaptive immune response","volume":"26","author":"Linares-Fern\u00e1ndez","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152950_bib58","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.vaccine.2009.04.022","article-title":"Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology","volume":"27","author":"Kimman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152950_bib59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/vaccines9111345","article-title":"The importance of RNA-based vaccines in the fight against COVID-19: an overview","volume":"9","author":"Machado","year":"2021","journal-title":"Vaccines."},{"key":"10.1016\/j.bbrc.2025.152950_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152950_bib61","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/JVI.76.9.4241-4250.2002","article-title":"Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain","volume":"76","author":"Ostrowski","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.152950_bib62","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1099\/jgv.0.000006","article-title":"C3H strain of mouse mammary tumour virus, like GR strain, infects human mammary epithelial cells, albeit less efficiently than murine mammary epithelial cells","volume":"96","author":"Konstantoulas","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2025.152950_bib63","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1128\/JVI.79.19.12495-12506.2005","article-title":"Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus","volume":"79","author":"Wissink","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.152950_bib64","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.vaccine.2005.12.049","article-title":"DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity","volume":"24","author":"Jiang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.152950_bib65","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/v16040544","article-title":"The mRNA vaccine expressing single and fused structural proteins of porcine reproductive and respiratory syndrome induces strong cellular and humoral immune responses in balB\/C mice","volume":"16","author":"Zhou","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152950_bib66","series-title":"Study of a Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain as a Vaccine Candidate","author":"Sun","year":"2017"},{"key":"10.1016\/j.bbrc.2025.152950_bib67","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"MRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib68","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152950_bib69","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152950_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41421-022-00517-9","article-title":"Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2","volume":"9","author":"Ai","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.bbrc.2025.152950_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2024.101783","article-title":"From discovery to innovation in animal health: maturing emerging technologies for industrial development","volume":"87","author":"Charlier","year":"2024","journal-title":"Biologicals"},{"key":"10.1016\/j.bbrc.2025.152950_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/applmicrobiol5030083","article-title":"Revolutionizing veterinary vaccines: overcoming cold-chain barriers through thermostable and novel delivery technologies","volume":"5","author":"Raut","year":"2025","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152950_bib73","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fvets.2020.00500","article-title":"Modeling economic effects of vaccination against porcine reproductive and respiratory syndrome: impact of vaccination effectiveness, vaccine price, and vaccination coverage","volume":"7","author":"Thomann","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202500270","article-title":"Bioengineered extracellular vesicles in emerging cancer vaccine platforms","author":"Ahn","year":"2025","journal-title":"Small Sci."},{"key":"10.1016\/j.bbrc.2025.152950_bib75","article-title":"Enhancing vaccine quality and accessibility: strategies for efficient storage and distribution in resource-constrained environment","volume":"1","author":"Scott","year":"2025","journal-title":"Outbreak Manag. Resp."},{"key":"10.1016\/j.bbrc.2025.152950_bib76","series-title":"From Nutritional Support to Innovative Vaccines: Approaches to Bolster the Immune Response to Respiratory Infection","author":"Hong","year":"2024"},{"key":"10.1016\/j.bbrc.2025.152950_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/v9060148","article-title":"Mechanisms of adaptive immunity to porcine reproductive and respiratory syndrome virus","volume":"9","author":"Rahe","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152950_bib78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s43586-023-00246-7","article-title":"Nanotechnology-based mRNA vaccines","volume":"3","author":"Chen","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.bbrc.2025.152950_bib79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-animal-022114-111025","article-title":"Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system","volume":"4","author":"Lunney","year":"2016","journal-title":"Annual Rev. Animal Biosci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:41:49Z","timestamp":1764103309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25016663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S0006291X25016663"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152950","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA vaccines for porcine reproductive and respiratory syndrome: A new paradigm in swine health","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152950"}}